Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

Update on response to Nature commentary

  • Creator
    Discussion
  • #101869

    Mary Uhlmansiek
    Participant

    Dear all,
    The group has made tremendous progress on the response to the recent Nature article, and hopes to finalize it early next week. I’ve sent out an invitation for a writing sprint on Monday, 22 March at 11:00 UTC if you are able to join. Here is the link to the draft if you’d like to provide comments/suggestions: https://docs.google.com/document/d/1tWEz_N–b4gqU2wD7jSj2E8KVTCfLvsoQ4ai
    Thanks again for all of your time and effort on this initiative, and have a great weekend.
    Best,
    Mary
    Mary O’Brien Uhlmansiek, MA
    Director, Implementation & Outreach
    Research Data Alliance – US/RA
    Member, RDA Secretariat
    https://www.rd-alliance.org
    ORCID: 0000-0002-7949-2057
    Skype: maryuhlmansiek
    ___________________________________________________________________________________
    RDA 17th Plenary Meeting, April 2021, Edinburgh, Scotland – see updates
    IDW2021 (co-organised by RDA, CODATA and WDS and incorporates 18th RDA Plenary Meeting), 8-11 November 2021, Seoul, Republic of Korea – see updates
    IDW2023 (co-organised by RDA, CODATA and WDS and incorporating the RDA Plenary Meeting), 23-26 October 2023, Salzburg, Austria – see updates

    Homepage

  • Author
    Replies
  • #129528

    All,
    The commentary is progressing, and it looks like we will need at least one more meeting to get it finalized and in the required format for submission to Nature. Of note, a Correspondence submission only allows for 250 words, so the draft may have to be shortened significantly.
    We are aiming for a meeting on Thursday; if interested in joining, please indicate your availability here: https://doodle.com/poll/vz2zpuybhp7nn5d2?utm_source=poll&utm_medium=link
    Thanks and regards,
    Mary
    From: on behalf of muhlmansiek via RDA COVID19 Coordination
    Reply-To: Mary O’Brien Uhlmansiek
    Date: Friday, March 19, 2021 at 07:28
    To: RDA COVID19 Coordination , Zoe Cournia , “***@***.***
    Subject: [rdacovid19-coordination] Update on response to Nature commentary
    Dear all,
    The group has made tremendous progress on the response to the recent Nature article, and hopes to finalize it early next week. I’ve sent out an invitation for a writing sprint on Monday, 22 March at 11:00 UTC if you are able to join. Here is the link to the draft if you’d like to provide comments/suggestions: https://docs.google.com/document/d/1tWEz_N–b4gqU2wD7jSj2E8KVTCfLvsoQ4ai
    Thanks again for all of your time and effort on this initiative, and have a great weekend.
    Best,
    Mary
    Mary O’Brien Uhlmansiek, MA
    Director, Implementation & Outreach
    Research Data Alliance – US/RA
    Member, RDA Secretariat
    https://www.rd-alliance.org
    ORCID: 0000-0002-7949-2057
    Skype: maryuhlmansiek
    ___________________________________________________________________________________
    RDA 17th Plenary Meeting, April 2021, Edinburgh, Scotland – see updates
    IDW2021 (co-organised by RDA, CODATA and WDS and incorporates 18th RDA Plenary Meeting), 8-11 November 2021, Seoul, Republic of Korea – see updates
    IDW2023 (co-organised by RDA, CODATA and WDS and incorporating the RDA Plenary Meeting), 23-26 October 2023, Salzburg, Austria – see updates

    Homepage

  • #129527

    I have proposed a modification of the last paragraph of the short
    version made by Claire. Not sure I can be persent for the next sprint.
    Anne

  • #129526

    I think Claire has managed to capture all the key points – I made some minor edits to try and rhetorically clarify our key point (which is ‘good example in bioinformatics’ AND this is wider’ (vs ‘Good example in biometrics, you missed that this is wider’).
    I don’t think I can make the sprint tomorrow, but I added a note about FAIRER – I believe it should be kept as FAIR – this has been discussed before in the WG and the decision was to not extend it to FAIRER.
    Best,
    Natalie
    _______
    Read our statement on ‘Playing Our Part during COVID-19’
    _________________
    Dr. Natalie Harrower
    Director, Digital Repository of Ireland
    Royal Irish Academy
    ***@***.*** | @natalieharrower
    http://www.dri.ie | @dri_ireland
    RDA COVID-19 Working Group
    European Commission FAIR data expert group
    European Open Science Cloud (EOSC) FAIR working group
    On 24 Mar 2021, at 09:46, cambonthomsen via RDA COVID19 Coordination wrote:
    I have proposed a modification of the last paragraph of the short version made by Claire. Not sure I can be persent for the next sprint.
    Anne
    Le 23/03/2021 à 19:19, muhlmansiek via RDA COVID19 Coordination a écrit :
    All,
    The commentary is progressing, and it looks like we will need at least one more meeting to get it finalized and in the required format for submission to Nature. Of note, a Correspondence submission only allows for 250 words, so the draft may have to be shortened significantly.
    We are aiming for a meeting on Thursday; if interested in joining, please indicate your availability here: https://doodle.com/poll/vz2zpuybhp7nn5d2?utm_source=poll&utm_medium=link
    Thanks and regards,
    Mary
    From: on behalf of muhlmansiek via RDA COVID19 Coordination
    Reply-To: Mary O’Brien Uhlmansiek
    Date: Friday, March 19, 2021 at 07:28
    To: RDA COVID19 Coordination , Zoe Cournia , “***@***.***
    Subject: [rdacovid19-coordination] Update on response to Nature commentary
    Dear all,
    The group has made tremendous progress on the response to the recent Nature article, and hopes to finalize it early next week. I’ve sent out an invitation for a writing sprint on Monday, 22 March at 11:00 UTC if you are able to join. Here is the link to the draft if you’d like to provide comments/suggestions: https://docs.google.com/document/d/1tWEz_N–b4gqU2wD7jSj2E8KVTCfLvsoQ4ai
    Thanks again for all of your time and effort on this initiative, and have a great weekend.
    Best,
    Mary
    Mary O’Brien Uhlmansiek, MA
    Director, Implementation & Outreach
    Research Data Alliance – US/RA
    Member, RDA Secretariat
    https://www.rd-alliance.org
    ORCID: 0000-0002-7949-2057
    Skype: maryuhlmansiek
    ___________________________________________________________________________________
    RDA 17th Plenary Meeting, April 2021, Edinburgh, Scotland – see updates
    IDW2021 (co-organised by RDA, CODATA and WDS and incorporates 18th RDA Plenary Meeting), 8-11 November 2021, Seoul, Republic of Korea – see updates
    IDW2023 (co-organised by RDA, CODATA and WDS and incorporating the RDA Plenary Meeting), 23-26 October 2023, Salzburg, Austria – see updates

    Full post: https://www.rd-alliance.org/group/rda-covid19-coordination/post/update-r
    Manage my subscriptions: https://www.rd-alliance.org/mailinglist
    Stop emails for this post: https://www.rd-alliance.org/mailinglist/unsubscribe/73120

    Dr Anne Cambon-Thomsen
    Directrice de recherche émérite au CNRS
    CERPOP, UMR 1295, Inserm, Université de Toulouse, Université Toulouse III – Paul Sabatier http://www.u1027.inserm.fr
    Equipe BIOETHICS : “Trajectoires d’innovations en santé : enjeux bioéthiques et sociétaux”
    Plateforme sociétale genotoul http://societal.genotoul.fr/
    Ambassador of the Research Data Alliance (RDA) for health sciences and research ethics http://www.rd-alliance.org
    37 allées Jules Guesde F-31073 Toulouse Cedex
    Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48 Fax : +33 (0)5 61 14 56 23 Skype: act_pro
    E-mail :

    Full post: https://www.rd-alliance.org/group/rda-covid19-coordination/post/update-r
    Manage my subscriptions: https://www.rd-alliance.org/mailinglist
    Stop emails for this post: https://www.rd-alliance.org/mailinglist/unsubscribe/73120
    The Academy is subject to the FOI Act 2014, the Data Protection Acts 1988-2003 and 2018, GDPR (EU 2016/679) and S.I. No. 336/2011, EC Privacy & Electronic Communications Regulations. For further information see our website http://www.ria.ie/privacy-and-data-protection

    Homepage

Log in to reply.